Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions
- 3 July 2026
- journal article
- Published by Elsevier in Cells & Development
- Vol. 187, 204096
Abstract
No abstract availableKeywords
Funding Information
- Agencia Nacional de Investigación y Desarrollo
This publication has 52 references indexed in Scilit:
- The role of VEGF in Cancer angiogenesis and tumorigenesis: Insights for anti-VEGF therapyCytokine, 2025
- Efficacy and safety of the combination of estetrol 15 mg/drospirenone 3 mg in a cyclic regimen for the treatment of endometriosis-associated pain and objective gynecological findings: a multicenter, placebo-controlled, double-blind, randomized studyFertility and Sterility, 2024
- The effect of GnRH-a on the angiogenesis of endometriosisHormones, 2024
- Mouse model for endometriosis is characterized by proliferation and inflammation but not epithelial-to-mesenchymal transition and fibrosisJournal of Biosciences, 2020
- Local estrogen formation and its regulation in endometriosisReproductive Medicine and Biology, 2019
- Medical treatment of endometriosis-related painBest Practice & Research Clinical Obstetrics & Gynaecology, 2018
- Comparison of Serum and Tissue Levels of Trace Elements in Different Models of Cervical CancerBiological Trace Element Research, 2014
- Independent Anti‐Angiogenic Capacities of Coagulation Factors X and XaJournal of Cellular Physiology, 2014
- Pathogenesis and pathophysiology of endometriosisFertility and Sterility, 2012
- Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro studyFertility and Sterility, 2007